Sion­na seeks $135M IPO to fu­el tests of cys­tic fi­bro­sis drug can­di­dates

Cys­tic fi­bro­sis drug de­vel­op­er Sion­na Ther­a­peu­tics hopes to join the IPO wave start­ed by Met­sera and Maze Ther­a­peu­tics last week.

Sion­na, which snagged some of …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER